SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 7.76 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 4.21 |
| Book Value / Share | 1.42 |
| Price / Book | n/a |
| NCAV ($M) | -12.78 |
| NCAV / Share | -4.30 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.65 |
| Return on Assets (ROA) | -0.25 |
| Return on Equity (ROE) | -0.65 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.59 |
| Current Ratio | 0.70 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 27.64 |
| Assets | 44.63 |
| Liabilities | 40.42 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,392 | 18,583 | 7.49 | |
| 2,625 | 8,591 | 30.56 | |
| 923 | 5,930 | 15.56 | |
| 1,808 | 4,896 | 36.93 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| HRTX – Heron Therapeutics, Inc. | ICCC – ImmuCell Corporation |
| IKT – Inhibikase Therapeutics, Inc. | IMMX – Immix Biopharma, Inc. |
| IMNM – Immunome, Inc. |
Financial data and stock pages provided by
Fintel.io